Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Recruiting 2Withdrawn 1Unknown 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gastrointestinal 4Other neoplasm 1

Conditions

Gastrointestinal Neoplasms 1Gastrointestinal Malignancy 1Esophageal Neoplasms 1Colorectal Neoplasms 1

Interventions

Oxaliplatin 1439Fluorouracil 1319Capecitabine 1114Gemcitabine 1057Leucovorin 939Bevacizumab 847Irinotecan 830Cisplatin 676Radiotherapy 560Cetuximab 482pembrolizumab 435Paclitaxel 401Drug Therapy 358Nivolumab 350130-nm albumin-bound paclitaxel 329Docetaxel 290Sorafenib 288S 1 (combination) 279Folfox protocol 266Albumin-Bound Paclitaxel 263Surgical Procedures, Operative 258lenvatinib 222sintilimab 218tislelizumab 214durvalumab 212regorafenib 209Magnetic Resonance Spectroscopy 205apatinib 204Radiosurgery 204Neoadjuvant Therapy 190

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Electrocardiography, Ambulatory × Gastrointestinal × Clear all
NCT07456852 2026-06-02

Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine Therapy

Mayo Clinic

Phase 1/2 Recruiting
60 enrolled
Gastrointestinal

Gastrointestinal Neoplasms

NCT06538610 2024-12-09

The 5-FU Holter Study

University of Auckland, New Zealand

Phase NA Recruiting
10 enrolled
Gastrointestinal

Gastrointestinal Malignancy

NCT04835987 2023-11-24

PROSNACO

Centre Hospitalier Universitaire de Saint Etienne

Withdrawn
Gastrointestinal

Esophageal Neoplasms

NCT04037319 2021-10-08

AFAR

Sheffield Teaching Hospitals NHS Foundation Trust

Unknown
720 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡